India’s Serum Institute will increase production of the AstraZeneca-Oxford COVID-19 vaccine by nearly 40 per cent in June, officials said on Monday, in a key step toward alleviating a shortage that has worsened the country’s battle with the illness.
India accelerates COVID-19 vaccine production in bid to avoid another wave
